The effects of intensive voice treatment on facial expressiveness in Parkinson disease: Preliminary data

Cognitive and Behavioral Neurology

Volumn 16, Issue 3, 2003, Pages 177-188

  Spielman, Jennifer L ^a   Borod, Joan C ^b,c   Ramig, Lorraine O ^a,d  

^a Denver Center for the Performing Arts   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

Communication; Facial expression; Parkinson disease; Voice therapy

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FACIAL EXPRESSION; GESTURE; HUMAN; INTERPERSONAL COMMUNICATION; LOUDNESS; PARKINSON DISEASE; PHONATION; PRIORITY JOURNAL; RESPIRATORY CARE; SPEECH REHABILITATION;

AGED; COMMUNICATION; FACIAL EXPRESSION; FEMALE; HUMANS; MALE; PARKINSON DISEASE; PULMONARY VENTILATION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VIDEO RECORDING; VOICE DISORDERS; VOICE TRAINING;

EID: 0141954269     PISSN: 15433633     EISSN: None     Source Type: Journal    
DOI: 10.1097/00146965-200309000-00005     Document Type: Article

References (53)

1. Logemann J, Fisher H, Boshes B, et al. Frequency and concurrence of vocal tract dysfunctions in the speech of a large sample of Parkinson patients. J Speech Hear Disord. 1978;42:47-57.
2. Fox C, Ramig LO. Vocal sound pressure level and self-perception of speech and voice in men and women with idiopathic Parkinson disease. Am J Speech Lang Path. 1997;6:85-94.
3. Stewart C, Winfield L, Hunt A, et al. Speech dysfunction in early Parkinson's disease. Mov Dis. 1995;10: 562-565.
4. Rinn W. The neuropsychology of facial expression: A review of the neurological and psychological mechanisms for producing facial expressions. Psychol Bull. 1984;95:52-77.
5. Smith MC, Smith MK, Ellgring H. Spontaneous and posed facial expression in Parkinson's disease. J Int Neuropsychol Soc. 1996;2:383-391.
6. Madeley P, Ellis A, Mindham R. Facial expressions and Parkinson's disease. Behav Neurol. 1995;8:115-119.
7. Pentland B, Pitcairn TK, Gray JM, et al. The effects of reduced expression in Parkinson's disease on impression formation by health professionals. Clin Rehabil. 1987;1:307-313.
8. Pitcairn TK, Clemie S, Gray JM, et al. Non-verbal cues in the self-presentation of Parkinsonian patients. Br J Clin Psychol. 1990a;29:177-184.
9. Riggio RE, Friedman HS. Impression formation: the role of expressive behavior. J Pers Soc Psychol. 1986;50:421-427.
10. Katsikitis M, Pilowsky I. A controlled quantitative study of facial expression in Parkinson's disease and depression. J Nerv Ment Dis. 1991;179:683-688.
11. Arndt H, Janney RW. Verbal, prosodic, and kinesic emotive contrasts in speech. J Pragmat. 1991;15: 521-549.
12. Coker DA, Burgoon JK. The nature of conversational involvement and nonverbal encoding patterns. Hum Commun Res. 1987;13:463-494.
13. Borod JC, Brickman A. Emotional processing deficits in Parkinson's disease: A review of the literature. J Int Neuropsychol Soc. 2001;7:243-244. [Abstract]
14. Katsikitis M, Pilowsky I. A controlled study of facial mobility treatment in Parkinson's disease. J Psychosom Res. 1996;40:387-396.
15. Robertson S, Thomson F. Speech therapy in Parkinson's disease: a study of the efficacy and long term effects of intensive treatment. Br J Disord Commun. 1984;19:213-224.
16. Baker K, Ramig LO, Johnson A, et al. Preliminary voice and speech analysis following fetal dopamine transplants in 5 individuals with Parkinson disease. J Speech Lang Hear Res. 1997;40:615-626.
17. Schultz G, Grant M. Effects of speech therapy and pharmacologic and surgical treatments on voice and speech in Parkinson's disease: A review of the literature. J Commun Dis. 2000;33:59-88.
18. Ramig L, Sapir S, Countryman S, et al. Intensive voice treatment (LSVT) for patients with Parkinson's disease: A 2 year follow up. J Neurol Neurosurg Psychiatry. 2001;71:493-498.
19. Ramig L, Countryman S, Thompson L, et al. Comparison of two forms of intensive speech treatment for Parkinson's disease. J Speech Hear Res. 1995;38: 1232-1251.
20. Ramig L, Countryman S, O'Brien C, et al. Intensive speech treatment for patients with Parkinson's disease: Short and long-term comparison of two techniques. Neurology. 1996;47:1496-1504.
21. Ramig L, Sapir S, Fox C, et al. Changes in vocal loudness following intensive voice treatment (LSVT) in individuals with Parkinson's disease: A comparison with untreated patients and normal age-matched controls. Mov Dis. 2001;16:79-83.
22. Baumgartner C, Sapir S, Ramig L. Voice quality changes following phonatory-respiratory effort treatment (LSVT) versus respiratory effort treatment for individuals with Parkinson's disease. J Voice. 2001;15:105-114.
23. Smith ME, Ramig L, Dromey C, et al. Intensive voice treatment in Parkinson's Disease: Laryngostroboscopic findings. J Voice. 1995;9:453-459.
24. Dromey C, Ramig LO, Johnson AB. Phonatory and articulatory changes associated with increased vocal intensity in Parkinson disease: A case study. J Speech Hear Res. 1995;38:751-764.
25. Spielman J, Ramig LO, Story BH, et al. Changes in vowel space and formant frequencies in Parkinson's disease following intensive voice therapy (LSVT). Paper presented at: Conference on Motor Speech Disorders; 2002; Williamsburg, VA.
26. Sapir S, Spielman J, Ramig LO, et al. Effects of intensive voice treatment (the Lee Silverman Voice Treatment, LSVT) on ataxic dysarthria: a case study. Am J Speech Lang Path. 2003;(In press)
27. McClean MD, Tasko SM. Association of orofacial with laryngeal and respiratory motor output during speech. Exp Brain Res. 2002;146:481-489.
28. Borod JC, Welkowitz J, Alpert M, et al. Parameters of emotional processing in neuropsychiatric disorders: conceptual issues and a battery of tests. J Commun Disord. 1990;23:247-271.
29. Devinsky O, Morrell M, Vogt B. Contribution of anterior cingulate cortex to behavior. Brain. 1995; 118:279-306.
30. Trosch R, Sze G, Brass L, et al. Emotional facial paresis with striatocapsular infarction. J Neurol Sci. 1990;98:195-201.
31. Hopf H, Muller-Forell W, Hopf N. Localization of emotional and volitional facial paresis. Neurology. 1992;42:1918-1923.
32. Ross R, Mathiesen R. Volitional and emotional supranuclear facial weakness. New Engl J Med. 1998;338: 1515.
33. Jurgens U, Zwirner P. The role of the periaqueductal gray in limbic and neocortical vocal fold control. Neuroreport. 1996;7:2921-2923.
34. Spielman J, Ramig LO, Borod JC. Preliminary effects of voice therapy on facial expression in Parkinson's disease. J Intl Neuropsychol Soc. 2001;7:244.
35. Hoehn M, Yahr M. Parkinsonism: Onset, progression and mortality. Neurology. 1967;17:427-442.
36. Fahn S, Elton RL. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Goldstein M, Caine D, eds. Recent Developments in Parkinson's Disease. Florham Park, NJ: Lacmillan Healthcare Information; 1987:153-163.
37. Borod JC, Koff E. Hemiface mobility and facial expression asymmetry. Cortex. 1983;19:355-361.
38. Canino E, Borod JC, Madigan N, et al. Development of procedures for rating posed emotional expressions across facial, prosodic, and lexical channels. Percept Mot Skills. 1999;89:57-71.
39. Benton AL, Hamsher KD, Varney NR, et al. Contributions to Neuropsychological Assessment. New York, NY: Oxford University Press; 1983.
40. Benton AL, Sivan AB, Hamsher KD, et al. Contributions to Neuropsychological Assessment, 2nd ed. New York, NY: Oxford University Press; 1994.
41. Siegel S. Nonparametric Statistics for the Behavioral Sciences, 2nd ed. New York, NY: McGraw-Hill; 1956.
42. Tanaka T, Yu H, Kitai ST. Trigeminal and spinal inputs to the facial nucleus. Brain Res. 1971;33:504-508.
43. Baumel J. Trigeminal-facial nerve communications. Their function in facial muscle innervation and reinnervation. Arch Otolaryngol. 1974;99:34-43.
44. Porges S. Orienting in a defensive world: Mammalian modifications of our evolutionary heritage. A polyvagal theory. Psychophysiology. 1995;32:301-318.
45. El-Sharkawi A, Ramig L, Logemann JA, et al. Swallowing and voice effects of Lee Silverman Voice Treatment: A pilot Study. J Neurol Neurosurg Psychiatry. 2002;72:31-36.
46. Liepert J, Bauder H, Wolfgang HR, et al. Treatment-induced cortical reorganization after stroke in humans. Stroke. 2000;31:1210-1216.
47. Liotti M, Ramig LO, Vogel D, et al. Hypophonia in Parkinson's disease: Neural correlates of voice treatment revealed by PET. Neurology. 2003;60:432-440.
48. Schaechter JD, Kraft E, Hilliard TS, et al. Motor recovery and cortical reorganization after constraint-induced movement therapy in stroke patients: a preliminary study. Neurorehabil Neural Repair. 2002; 16:326-338.
49. Porges S. Emotion: an evolutionary by-product of the neural regulation of the autonomic nervous system. Ann N Y Acad Sci. 1997;807:62-77.
50. Poewe W, Luginger E. Depression in Parkinson's disease: impediments to recognition and treatment options. Neurology. 1999;52:S2-S6.
51. Raskin SA, Borod JC, Tweedy J. Neuropsychological aspects of Parkinson's disease. Neuropsychol Rev. 1990;1:185-221.
52. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
53. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-389.